New Prescribing Regulations for Pharmacists

0 Comments

Newfoundland and Labrador Regulation 25/23 provides revisions to the regulatory framework governing pharmacist prescribing practices in the province. The amendments aim to advance pharmacists’ roles in patient care by expanding their responsibilities and refining existing regulations.

Modifications to Section 3 now permit pharmacists to authorize prescriptions for hormonal contraceptives and post-exposure prophylaxis, thereby broadening their scope in both preventive and emergency care contexts. Post-exposure prophylaxis (PEP) refers to medical treatments administered after potential exposure to a disease or infection to prevent the onset of illness. The goal of PEP is to reduce the risk of developing a disease after an individual has been exposed to a pathogen. PEP is most commonly used in the context of certain infectious diseases.

Section 7 has been comprehensively revised to standardize prescription extensions. Pharmacists are now permitted to extend prescriptions multiple times, but are restricted from extending them beyond 12 months from the initial prescription date or issuing more than a 90-day supply per extension.
Section 11 has been updated to reflect a revised list of conditions and minor ailments that pharmacists are authorized to treat, as specified in the updated Schedule A.

Section 11.1 introduces a requirement for pharmacists to obtain a referral from a regional medical officer of health or their designate before prescribing post-exposure prophylaxis. This ensures that such critical prescriptions are overseen by appropriate public health authorities.

Schedule A has been updated to include a broader range of conditions, from acne and allergic rhinitis to fungal infections and mild musculoskeletal pain. This expanded list reflects a more comprehensive approach to the management of minor ailments by pharmacists.

By broadening prescribing authority and refining guidelines for prescription extensions and referrals, these regulations aim to improve patient access to medications and streamline healthcare delivery.

Source: Newfoundland & Labrador (25/23) April 6, 2023